Peer Review History
| Original SubmissionMay 7, 2025 |
|---|
|
PONE-D-25-22997 Phyllosphere microbial communities are modulated by pathogen coinfection, but not a plant defense hormone PLOS ONE Dear Dr. Geyer, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected. I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision. Kind regards, Eugenio Llorens Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: No Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: No ********** Reviewer #1: The purpose of this study was to examine how sequential exposure to salicylic acid and a foliar fungal pathogen would influence the diversity, community structure, and differential abundance of both the fungal and bacterial communities of tall fescue. In general, the investigated treatments influenced neither the bacterial or fungal community structure nor differential abundance. The initial conclusion of the discussion is not well supported by the results. Fungal community composition variation was low in the co-inoculated (line 400-404); not “significant changes” as stated in the discussion. Whether fungi and bacteria interact with each other was not directly examined by this study and such should be removed from the discussion. The authors suggest that their fungal pathogens create necrotic lesions which would be favored by decomposer fungi and yet, most inoculated plants in this study remained asymptomatic. As for the findings from the salicylic acid treatment, the authors should have a better rationale for their chosen concentration. It’s possible that their concentration wasn’t biologically relevant to their host. Reviewer #2: The manuscript suffers from several critical shortcomings that compromise its scientific rigor, clarity, and contribution to the field. The following key issues highlight the major flaws in the study: • The research question is poorly justified, and the study does not offer a novel contribution to the existing body of knowledge. • The literature review is insufficient, lacking a comprehensive discussion of recent and relevant studies. • The study appears to replicate previous findings without introducing significant innovation or new insights. • The methodology is inadequately described, making replication difficult. • The sample size is too small to draw meaningful conclusions, and statistical validation is weak. • The experimental design lacks proper controls, leading to questionable reliability. • Key parameters and variables are either not defined or inconsistently reported. • The data analysis is superficial and does not provide a strong basis for the conclusions drawn. • Statistical tests are either inappropriate or poorly applied, leading to misleading interpretations. • The results are not presented logically, making it difficult to follow the study’s findings. • The discussion section lacks depth and does not critically engage with the results in the context of existing literature. • Figures and tables are not well-integrated into the discussion, and some data appear redundant or irrelevant. • The authors overstate the significance of their findings without sufficient supporting evidence. • The manuscript contains numerous grammatical and typographical errors, which hinder readability. • The writing lacks coherence, and many sections are either repetitive or unclear. • Formatting inconsistencies in citations, references, and section headings make the manuscript difficult to follow. • The conclusion is vague and does not adequately summarize the key findings. • The study's limitations are not acknowledged, giving a misleading impression of the research's reliability. • No clear recommendations for future research are provided. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] - - - - - For journal use only: PONEDEC3 |
| Revision 1 |
|
Dear Dr. Geyer, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Eugenio Llorens Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: (No Response) Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #3: In this study Geyer, Grunberg and Mitchell, investigated how application of hormone salicylic acid and coinfection by two fungal pathogens influenced fungal and bacterial communities on leaves of Lolium arundinaceum. I believe that the experimental design is well developed and the results are in line with the methods and objectives of the study. However, I have some concerns, which are outlined below. The authors do not clearly explain why they decided to use R. solani and C. cereale in their experiments. Is this co-infection possible in nature? Are they natural pathogens of L. arundinaceum? What other defenses besides chemical defense does this plant have to prevent infection by pathogens? Beyond the taxonomic identity of the fungal and bacterial species found, what information do the authors have about their biology and interactions in the context of a bacterial community? I understand that this is an experimental manuscript, but I am concerned that both the approach of the manuscript and the discussion of the results do not take into account what occurs under natural conditions. Under natural conditions, how does infection occur in this plant species? Or in grasses in general? What are the implications in an ecological context for microorganism communities? Or in an evolutionary context for plant defense against herbivores? It is not entirely clear why coinfection could modify microbial communities, compared to simple infections. At least, this is not explicitly stated. Including some predictions and hypotheses could help the reader. Line 68, the idea is unclear. Line 65, the authors attempt to explain the main idea of the manuscript, but it is confusing. Providing some examples of possible scenarios would give the reader more clarity. Linea 85, It is difficult for me to understand why treatment with salicylic acid is the control treatment. Methods Line 95, Line 141, What does the control solution contain? Line 265, Could you describe the characteristics of a symptomatic infection? Reviewer #4: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Phyllosphere microbial communities are modulated by pathogen coinfection, but not a plant defense hormone PONE-D-25-22997R2 Dear Dr. Geyer, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Eugenio Llorens Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: All comments have been addressed Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes Reviewer #4: Yes ********** Reviewer #3: I have no further comments on the manuscript. The authors address all my comments from the previous version. Reviewer #4: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No Reviewer #4: Yes: Dr. Muhammad Abrar ********** |
| Formally Accepted |
|
PONE-D-25-22997R2 PLOS One Dear Dr. Geyer, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Eugenio Llorens Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .